Carbidopa And Levodopa
Product Images NDC 67544-672

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Carbidopa And Levodopa (NDC 67544-672). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bottle Label 50/200 mg (67544 672 51)

Carbidopa-levodopa ER is a medication used to treat Parkinson's disease symptoms such as tremors, stiffness, and difficulty with movement. It is a combination of carbidopa, which helps prevent levodopa from being broken down before it reaches the brain, and levodopa, which is converted into dopamine in the brain. The "ER" in the name stands for "extended release," meaning that the medication is released slowly over time to provide a steady dose throughout the day. It is important to follow your doctor's instructions carefully when taking carbidopa-levodopa ER.*

FDA Label Image

Carbidopa Structural Formula (9b9c2160 B304 4d70 9b49 6a14b6e149b3 01)

FDA Label Image

Levodopa Structural Formula (9b9c2160 B304 4d70 9b49 6a14b6e149b3 02)

FDA Label Image

Aphena Pharma Solutions (TN)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.